Lv11
75 积分 2021-02-02 加入
Effectiveness and safety of polatuzumab vedotin combined with zuberitamab plus cyclophosphamide, doxorubicin and prednisone in untreated diffuse large B-cell lymphoma: A real-world study from China
52分钟前
已关闭
[Polatuzumab vedotin, bendamustine, and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma, including the outcome as a bridging treatment to CAR-T cell therapy or allogeneic hematopoietic stem cell transplant]
3个月前
已关闭
Anti-CD22 and anti-CD79B antibody drug conjugates are active in different molecular diffuse large B-cell lymphoma subtypes
4个月前
已关闭
Superiority of polatuzumab vedotin over other novel agents in previously untreated ABC-type diffuse large B-cell lymphoma: a network meta-analysis of 20 RCTs
5个月前
已完结
Endoscopic approach to early gastric cancer in older adults
1年前
已完结
Clinical impact of evaluation of frailty in endoscopic submucosal dissection for early gastric cancer in elderly patients
1年前
已完结
Age Affects Clinical Management after Noncurative Endoscopic Submucosal Dissection for Early Gastric Cancer
1年前
已完结
Impact of the Charlson comorbidity index and prognostic nutritional index on prognosis in patients with early gastric cancer after endoscopic submucosal dissection
1年前
已完结
Endoscopic Submucosal Dissection is Feasible for Very Elderly Patients with Early Gastric Cancer : Comparison of Short-Term and Long-Term Outcomes in Very Elderly and Non-Elderly Patients
1年前
已关闭
Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study
1年前
已完结
皖公网安备34019202002308
